SOUTH EASTON, Mass., May 23, 2013 /PRNewswire/ -- Pressure BioSciences, Inc. (PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its First Quarter 2013 financial results and to provide a business update. The teleconference information is provided below:
Date: Thursday, May 23, 2013
Time: 11:00 a.m. Eastern Daylight Time (EDT)
Dial-in: (800) 875-3456 (U.S.); (800) 648-0973 (Canada); (302) 607-2001 (Int'l)
Passcode: VS22823
For those unable to participate in the live teleconference, a replay will be available approximately one hour after the call and will be accessible through the Company's website.
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. ("PBI") (PBIO) is focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology ("PCT"). PCT is a patented, enabling technology platform with multiple applications in the estimated $6 billion life sciences sample preparation market. PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. PBI currently focuses its efforts on the development and sale of PCT-enhanced sample preparation systems (instruments and consumables) for mass spectrometry, biomarker discovery, bio-therapeutics characterization, vaccine development, soil and plant biology, forensics, histology, and counter-bioterror applications.
For more information about PBI and this press release, please click on the following link:
http://www.pressurebiosciences.com
|
Investor Contacts: |
|
|
Richard T. Schumacher, President & CEO |
Pressure BioSciences, Inc. |
|
Conrad Mir, CFO |
(T) 508-230-1828 |
